查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017970

套管市場：按產品類型、材料類型、應用和最終用戶分類 - 2026-2032年全球市場預測

Cannula Market by Product Type, Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，套管市場價值將達到 1.8832 億美元，到 2026 年將成長到 2.0477 億美元，到 2032 年將達到 2.9843 億美元，複合年成長率為 6.79%。

主要市場統計數據
基準年 2025 1.8832億美元
預計年份：2026年 2.0477億美元
預測年份 2032 2.9843億美元
複合年成長率 (%) 6.79%

對影響現代外科和門診實踐的套管技術、臨床需求和採購趨勢進行了權威概述。

套管技術是眾多外科手術和微創手術的基礎，也是液體輸注、組織通路和器械插入的重要途徑。近年來，在感染控制、手術效率和患者舒適度等因素的驅動下，臨床醫生和採購團隊對器械的人體工學、滅菌流程以及一次性器械和可重複使用器械之間的權衡取捨表現出越來越濃厚的興趣。在許多專科領域，套管不再只是耗材，而是成為漸進式創新的焦點，這些創新能夠影響手術室的容量、術後恢復以及產品推廣應用。

技術、臨床實踐和監管領域的協同力量如何重新定義整個醫療保健環境中的插管設計、實施和價值創造。

導管裝置的格局正受到技術和製度因素共同作用的重塑，這些因素正在改變臨床醫生選擇和使用器械的方式。材料科學已超越了傳統的不銹鋼，多種材料被廣泛應用，包括用於提高強度重量比的鈦、用於減少組織損傷的矽塗層鋼，以及可用於製造經濟高效的一次性器械的工程塑膠。同時，諸如微型導管和多端口配置等以精準操作為導向的設計，正在滿足微創介入以及在組織操作和體液交換方面實現精準控制的需求。

評估近期關稅波動對投入成本的累積影響以及貿易政策變化對醫療設備製造穩定性的影響，包括供應鏈和採購。

近期影響進口和原料的貿易措施對醫療設備製造商的供應鏈策略產生了重大影響，其中插管製造商的應對措施包括採購多元化和產品重新設計。由於關稅導致特種合金和精密零件等關鍵原料成本上漲，製造商被迫重新審視其供應商合約和庫存政策。為此，許多公司正在加快替代供應商的認證，盡可能增加在地採購，並協商長期供應契約，以確保原料供應穩定並緩解價格波動。

以細分市場主導的洞察，揭示了特定應用需求、最終用戶背景、產品類型和材料選擇如何相互交織，從而影響臨床部署。

深入的市場區隔能夠讓我們細緻了解不同應用、最終用戶、產品類型和材料選擇下的臨床需求模式和產品設計要求。基於應用領域，關節關節鏡（包括髖關節鏡、關節鏡和關節鏡鏡）和關節鏡（例如雷射輔助抽脂術、水腫抽脂術和超音波輔助抽脂術）的需求促進因素存在顯著差異。每種應用都需要不同的孔徑、尖端形狀和流體特性。在眼科應用中，需求會進一步細分為白內障手術、青光眼手術和玻璃體切除手術等特定領域，其中微觀尺度的公差和光學適配性至關重要。

全球醫療保健市場競爭地位的決定因素—監管要求、採購模式和採用促進因素的區域比較。

區域趨勢導致監管預期、製造地和臨床應用模式的多樣性，這對製造商和採購商的策略都產生了重大影響。在美洲，採購規模和醫院採購聯盟強調成本效益、效率提升和感染控制，而門診中心和美容診所則對專用一次性產品和微型套管產生了強勁的需求。支付方的獎勵與門診服務的擴展之間的相互作用，正在加速那些能夠顯著縮短手術時間和減少術後併發症的醫療設備的普及應用。

產品差異化、供應鏈韌性和臨床合作策略如何為製造商和供應商提供競爭優勢。

套管領域的競爭格局由大型醫療設備製造商、專業外科耗材製造商以及支援快速設計改進和可擴展無菌供應的契約製造(CMO) 組成。主要企業正策略性地專注於差異化產品系列，涵蓋從無菌一次性產品到可重複使用的高級產品線，同時與臨床創新者建立夥伴關係，以加速產品在特定手術中的應用。研發投入通常著眼於能夠清晰傳達給臨床醫生的特定性能改進的漸進式設計優勢，例如低摩擦塗層、最佳化的尖端形狀和多孔微型套管結構。

為製造商、醫療保健系統和供應商制定具體的策略重點，透過平衡創新、供應鏈韌性和臨床醫生的採納來加速成長。

產業領導企業應採取綜合策略，平衡產品創新、供應鏈韌性和以臨床醫生為中心的商業化。製造商可以提供一次性使用和經驗證的可重複使用產品，以適應不同的採購模式，同時優先發展模組化產品線，滿足從高精度眼科果凍到可靠的關節鏡等特定應用需求。同時，增加對材料科學的投資，例如檢驗鈦合金以提升性能，或開發生物相容性塑膠以製造永續的一次性產品，將有助於減少對供應受限原料的依賴，並為買家提供更清晰的價值提案。

採用透明且可重複的混合方法研究途徑，結合對臨床醫生的訪談、監管審查和供應鏈分析，以檢驗行業洞察。

本研究結合了與關鍵相關人員的對話和嚴謹的二手資料研究，以確保證據基礎的穩健性和說服力。一手資料研究包括對整形外科、眼科和整形外科臨床醫生、醫院和門診中心採購負責人以及醫療設備製造商供應鏈經理進行結構化訪談，以確定營運限制、設計偏好和採購標準。二手資料研究涵蓋了同行評審的臨床文獻、監管文件、醫療設備標籤檢視和公開的供應商資訊披露，以檢驗訪談中觀察到的趨勢，並為設計和材料選擇提供背景信息。

本文簡要概述了設計創新、臨床證據和強力的採購如何共同決定不斷發展的插管領域的成功。

綜上所述，這些證據凸顯了套管技術在臨床療效、手術效率和供應鏈複雜性三者交會點上的關鍵作用。材料和設計的進步使得微創手術和日益專業化的手術工具包成為可能，而採購和監管要求則促使人們傾向於選擇無菌一次性產品和檢驗的可重複使用系統。由於監管嚴格程度、生產能力和醫療服務模式存在區域差異，因此需要製定符合當地優先事項的在地化商業化策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：套管市場：依產品類型分類

  • 免洗套管
    • 非無菌
    • 預先滅菌
  • 微型套管
    • 多埠
    • 單埠
  • 穿刺套管
    • 鈍頭
    • 特羅卡爾小貼士
  • 標準套管
    • 弧形字體
    • 直的

第9章：套管市場：依材料類型分類

  • 塑膠
  • 矽塗層鋼
  • 不銹鋼
  • 鈦

第10章：套管市場：依應用領域分類

  • 關節鏡
    • 髖關節鏡鏡手術
    • 膝關節關節鏡
    • 肩關節關節鏡
  • 抽脂手術
    • 雷射輔助抽脂手術
    • 腫脹法抽脂
    • 超音波輔助抽脂術
  • 眼科
    • 白內障手術
    • 青光眼手術
    • 玻璃體切除手術

第11章：套管市場：依最終用戶分類

  • 門診手術中心
  • 居家醫療環境
    • 居家照護套裝
    • 居家照護服務
  • 醫院
  • 專科診所
    • 皮膚科診所
    • 眼科診所
    • 整形外科診所

第12章：套管市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：套管市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：套管市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國套管市場

第16章：中國套管市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Fisher & Paykel Healthcare Ltd
  • Flexicare Medical Limited
  • Merit Medical Systems
  • Merit Medical Systems, Inc.
  • Smiths Group plc
  • Teleflex Incorporated
  • Terumo Corporation
  • Vyaire Medical, Inc.
Product Code: MRR-034230D3E2BD

The Cannula Market was valued at USD 188.32 million in 2025 and is projected to grow to USD 204.77 million in 2026, with a CAGR of 6.79%, reaching USD 298.43 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 188.32 million
Estimated Year [2026] USD 204.77 million
Forecast Year [2032] USD 298.43 million
CAGR (%) 6.79%

An authoritative orientation to cannula technologies, clinical demands, and procurement dynamics that frame modern surgical and ambulatory care pathways

Cannula technologies underpin an exceptionally wide range of surgical and minimally invasive procedures, serving as essential conduits for fluid transfer, tissue access, and instrumentation. Over recent years clinicians and procurement teams have elevated attention on device ergonomics, sterility pathways, and single-use versus reusable trade-offs, driven by priorities around infection prevention, procedural efficiency, and patient comfort. The cannula is no longer a commodity in many specialties; it represents a focal point for incremental innovation that can influence operating room throughput, post-operative recovery, and product adoption curves.

Clinically, cannula implementations span orthopedic arthroscopy, aesthetic liposuction, and ophthalmic microsurgery, each imposing distinct requirements for length, tip geometry, material composition, and sterility assurance. As a result, product development increasingly targets procedural specificity rather than one-size-fits-all designs. From the standpoint of health systems and specialty clinics, procurement strategies must reconcile capital constraints with evolving clinical preferences, while regulatory and sterilization considerations shape how devices are packaged, distributed, and used at point of care. With these pressures in mind, the introductory frame for this report emphasizes the interplay between clinical needs, supply chain realities, and innovation trajectories that define the contemporary cannula landscape.

How converging technological, clinical, and regulatory forces are redefining cannula design, deployment, and value creation across care settings

The landscape for cannula devices is being reshaped by convergent technological and systemic forces that alter how clinicians select and deploy instruments. Materials science is advancing beyond traditional stainless steel toward a spectrum that includes titanium for strength-to-weight gains, silicone-coated steel for reduced tissue trauma, and engineered plastics that enable cost-effective disposability. At the same time, precision-focused designs such as microcannula variants and multiport configurations are meeting the demand for less traumatic access and refined control in tissue manipulation and fluid exchange.

Operationally, care is migrating toward ambulatory surgical centers and homecare pathways, prompting manufacturers to prioritize packaging, ease of use, and pre-sterilized disposables to reduce the burden of in-house sterilization. Regulatory emphasis on infection control and single-use safety has elevated disposable cannula adoption while stimulating innovation around environmentally mindful materials and sterilization validation. Meanwhile, digital and procedural adjuncts-improved imaging, navigation tools, and point-of-care analytics-are influencing cannula design by dictating compatibility standards and tolerances. Together these shifts are transforming cannula selection from a narrow functional decision into a strategic choice with implications for patient outcomes, operational efficiency, and supplier relationships.

Assessing the cumulative supply chain and procurement effects of recent tariff-driven input cost shifts and trade policy changes on device manufacturing stability

Recent trade measures affecting imports and raw materials have had a notable influence on supply chain strategies for medical device manufacturers, and cannula producers are adapting through a combination of sourcing diversification and product redesign. Tariff-related increases in the cost of key inputs such as specialty alloys and precision components can pressure manufacturers to reassess supplier contracts and inventory policies. In response, many firms are accelerating qualification of alternate vendors, increasing local content where feasible, and negotiating long-term supply agreements to stabilize input availability and pricing volatility.

These adjustments have knock-on effects across the value chain. Hospitals and ambulatory centers face changing procurement dynamics as lead times, packaging formats, and pricing structures evolve. Contract manufacturers and original equipment manufacturers are expanding nearshore capabilities to mitigate border-related uncertainties, while clinicians and purchasing groups re-evaluate preferences for pre-sterilized disposable options versus reusable systems that depend on centralized sterilization infrastructure. The cumulative impact is a rebalancing of resilience and cost control priorities, with stakeholders emphasizing flexible sourcing, transparency in supplier risk profiles, and investments in design choices that reduce dependence on constrained or tariff-sensitive materials.

Segment-driven insights that reveal how application-specific requirements, end-user contexts, product typologies, and material choices converge to shape clinical adoption

Insightful segmentation yields a granular understanding of clinical demand patterns and product design imperatives across applications, end users, product typologies, and material choices. Based on Application, demand drivers differ markedly between Arthroscopy procedures-which include Hip Arthroscopy, Knee Arthroscopy, and Shoulder Arthroscopy-and Liposuction variants such as Laser-Assisted Liposuction, Tumescent Liposuction, and Ultrasound-Assisted Liposuction, each of which imposes distinct lumen sizes, tip geometries, and flow characteristics; Ophthalmic applications further refine requirements across Cataract Surgery, Glaucoma Surgery, and Vitrectomy, where microscale tolerances and optical compatibility take precedence.

Based on End User, adoption and procurement differ between Ambulatory Surgical Centers, Homecare Settings, Hospitals, and Specialty Clinics; Homecare Settings subdivide into Homecare Kits and Homecare Services that prioritize user-friendly, pre-sterilized components, while Specialty Clinics encompass Dermatology Clinics, Ophthalmic Clinics, and Plastic Surgery Clinics that demand differentiated portfolios tailored to office-based procedures. Based on Product Type, the field includes Disposable Cannula, Microcannula, Penetrating Cannula, and Standard Cannula; Disposable Cannula further divide into Non Sterile and Pre Sterilized formats, Microcannula into Multi Port and Single Port configurations, Penetrating Cannula into Blunt Tip and Trocar Tip options, and Standard Cannula into Curved and Straight forms, each choice reflecting trade-offs among trauma minimization, procedural control, and cost. Based on Material Type, selection spans Plastic, Silicone Coated Steel, Stainless Steel, and Titanium, with material properties affecting reusability, sterilization methods, radiopacity, and tactile feedback. Together these segmentation lenses illuminate where clinical need, end-user environment, and production considerations intersect to shape commercialization strategies and product roadmaps.

A comparative regional view of regulatory expectations, procurement models, and adoption drivers that determine competitive positioning across global healthcare markets

Regional dynamics present varied regulatory expectations, manufacturing footprints, and clinical adoption patterns that materially influence strategy for manufacturers and buyers alike. In the Americas, procurement scale and hospital purchasing consortia drive emphasis on cost-effectiveness, efficiency gains, and infection control, while ambulatory centers and aesthetic clinics create robust demand for specialized disposables and microcannula innovations. The interplay between payer incentives and ambulatory care expansion accelerates adoption of devices that demonstrate clear procedural time savings and reduced post-procedural complications.

In Europe, Middle East & Africa, regulatory harmonization efforts and centralized reimbursement frameworks influence product registration strategies and clinical evidence requirements, compelling manufacturers to present robust safety data and to navigate a heterogeneous patchwork of national procurement rules. Manufacturer investments in localized manufacturing and distribution are common to meet procurement preferences and reduce logistical complexity. In Asia-Pacific, a combination of rapidly expanding surgical volumes, rising outpatient care, and significant manufacturing capacity has created both intense competition and opportunity; manufacturers here focus on scalable production, cost-effective disposables, and close collaboration with clinical opinion leaders to drive adoption in a diverse set of healthcare delivery models. Across regions, supply chain resilience, regulatory alignment, and clinician training emerge as recurring themes that stakeholders must manage proactively.

How product differentiation, supply chain resilience, and clinical engagement strategies create competitive advantage for manufacturers and suppliers

Competitive dynamics in the cannula space reflect a mix of large medical device manufacturers, specialized surgical consumable firms, and contract manufacturers that support rapid design iterations and scalable sterilized supply. Leading players place strategic emphasis on differentiated portfolios that span disposable pre-sterilized options and reusable premium lines, while forging partnerships with clinical innovators to accelerate procedure-specific adoption. Research and development investments frequently target incremental design advantages such as low-friction coatings, optimized tip geometries, and multiport microcannula architectures that can be communicated clearly to clinicians as tangible performance improvements.

Supply chain strategies among successful companies increasingly include vertical integration of sterilization services, expanded nearshore manufacturing to shorten lead times, and enhanced quality systems to meet rigorous regulatory expectations. Companies that invest in clinician education, evidence generation, and service-level agreements with health systems often secure preferred supplier status because they reduce operational friction and support predictable outcomes. Finally, nimble firms that offer modular kits, procedural bundles, and compatibility across surgical platforms are well positioned to capture demand in ambulatory and office-based settings where simplicity and reliability are highly valued.

Actionable strategic priorities for manufacturers, health systems, and suppliers that balance innovation, supply chain resilience, and clinician adoption to accelerate growth

Industry leaders should pursue an integrated approach that balances product innovation with supply chain resilience and clinician-centric commercialization. Manufacturers can prioritize modular product ranges that address distinct application needs-from high-precision ophthalmic microsurgery to robust arthroscopic access-while offering both single-use and validated reusable options to accommodate diverse procurement models. Parallel investments in materials science, such as exploring titanium alloys for performance gains and biocompatible plastics for sustainable disposables, will reduce dependency on constrained inputs and provide clearer value propositions to purchasers.

Operationally, firms should diversify supplier bases and expand nearshore contract manufacturing to shorten lead times and reduce exposure to trade policy shocks. Providers and health systems ought to embed device selection criteria into procedural pathways, aligning clinical training, inventory management, and sterilization workflows so that device adoption yields measurable operational improvements. Finally, stakeholders should amplify evidence generation through targeted clinical studies and real-world registries to demonstrate comparative advantages in safety, efficiency, and patient-centered outcomes, thereby facilitating adoption across ambulatory, hospital, and homecare settings.

A transparent and reproducible mixed-methods research approach combining clinician interviews, regulatory review, and supply chain analysis to validate industry insights

This study synthesizes primary stakeholder engagement with rigorous secondary research to ensure a robust and defensible evidence base. Primary research included structured interviews with clinicians across orthopedics, ophthalmology, and aesthetic surgery, procurement officers at hospitals and ambulatory centers, and supply chain managers at device manufacturers to surface operational constraints, design preferences, and procurement criteria. Secondary research encompassed peer-reviewed clinical literature, regulatory filings, device labeling, and publicly available supplier disclosures to validate trends observed in interviews and to contextualize design and material choices.

Findings were triangulated using cross-validated inputs from clinical opinion leaders, sterilization specialists, and manufacturing engineers to reconcile technical specifications with real-world usability. Supply chain analysis incorporated upstream raw material sourcing, contract manufacturing landscapes, and logistics considerations to map potential vulnerability points. Throughout, the methodology emphasized reproducibility and transparency, documenting interview protocols, inclusion criteria for secondary sources, and the rationale for thematic categorization so that conclusions remain traceable to their underlying evidence.

A concise synthesis of how design innovation, clinical evidence, and resilient sourcing converge to determine success in the evolving cannula landscape

The collective evidence underscores that cannula technologies occupy a pivotal role at the intersection of clinical performance, procedural efficiency, and supply chain complexity. Advances in materials and design are enabling less invasive interventions and increasingly specialized procedural kits, while procurement and regulatory imperatives are reorienting preferences toward pre-sterilized disposables and validated reusable systems. Regional differences in regulatory rigor, manufacturing capacity, and care delivery models demand tailored commercialization strategies that reflect local priorities.

Moving forward, success in the field will hinge on an integrated set of capabilities: disciplined product development aligned with clinician needs, resilient sourcing and manufacturing footprints, and compelling evidence that links device choice to improved procedural outcomes and operational efficiencies. Organizations that coordinate these levers while maintaining close engagement with clinical adopters and procurement stakeholders will be best positioned to convert technological promise into measurable clinical and commercial results.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cannula Market, by Product Type

  • 8.1. Disposable Cannula
    • 8.1.1. Non Sterile
    • 8.1.2. Pre Sterilized
  • 8.2. Microcannula
    • 8.2.1. Multi Port
    • 8.2.2. Single Port
  • 8.3. Penetrating Cannula
    • 8.3.1. Blunt Tip
    • 8.3.2. Trocar Tip
  • 8.4. Standard Cannula
    • 8.4.1. Curved
    • 8.4.2. Straight

9. Cannula Market, by Material Type

  • 9.1. Plastic
  • 9.2. Silicone Coated Steel
  • 9.3. Stainless Steel
  • 9.4. Titanium

10. Cannula Market, by Application

  • 10.1. Arthroscopy
    • 10.1.1. Hip Arthroscopy
    • 10.1.2. Knee Arthroscopy
    • 10.1.3. Shoulder Arthroscopy
  • 10.2. Liposuction
    • 10.2.1. Laser-Assisted Liposuction
    • 10.2.2. Tumescent Liposuction
    • 10.2.3. Ultrasound-Assisted Liposuction
  • 10.3. Ophthalmic
    • 10.3.1. Cataract Surgery
    • 10.3.2. Glaucoma Surgery
    • 10.3.3. Vitrectomy

11. Cannula Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Homecare Settings
    • 11.2.1. Homecare Kits
    • 11.2.2. Homecare Services
  • 11.3. Hospitals
  • 11.4. Specialty Clinics
    • 11.4.1. Dermatology Clinics
    • 11.4.2. Ophthalmic Clinics
    • 11.4.3. Plastic Surgery Clinics

12. Cannula Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cannula Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cannula Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Cannula Market

16. China Cannula Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Baxter International Inc.
  • 17.7. Becton, Dickinson and Company
  • 17.8. Cardinal Health, Inc.
  • 17.9. Cook Medical LLC
  • 17.10. Fisher & Paykel Healthcare Ltd
  • 17.11. Flexicare Medical Limited
  • 17.12. Merit Medical Systems
  • 17.13. Merit Medical Systems, Inc.
  • 17.14. Smiths Group plc
  • 17.15. Teleflex Incorporated
  • 17.16. Terumo Corporation
  • 17.17. Vyaire Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CANNULA MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CANNULA MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CANNULA MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CANNULA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CANNULA MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CANNULA MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CANNULA MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CANNULA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CANNULA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CANNULA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CANNULA MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CANNULA MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CANNULA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CANNULA MARKET SIZE, BY NON STERILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CANNULA MARKET SIZE, BY NON STERILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CANNULA MARKET SIZE, BY NON STERILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CANNULA MARKET SIZE, BY PRE STERILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CANNULA MARKET SIZE, BY PRE STERILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CANNULA MARKET SIZE, BY PRE STERILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CANNULA MARKET SIZE, BY MICROCANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CANNULA MARKET SIZE, BY MICROCANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CANNULA MARKET SIZE, BY MICROCANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CANNULA MARKET SIZE, BY MULTI PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CANNULA MARKET SIZE, BY MULTI PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CANNULA MARKET SIZE, BY MULTI PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CANNULA MARKET SIZE, BY SINGLE PORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CANNULA MARKET SIZE, BY SINGLE PORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CANNULA MARKET SIZE, BY SINGLE PORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CANNULA MARKET SIZE, BY PENETRATING CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CANNULA MARKET SIZE, BY PENETRATING CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CANNULA MARKET SIZE, BY PENETRATING CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CANNULA MARKET SIZE, BY BLUNT TIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CANNULA MARKET SIZE, BY BLUNT TIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CANNULA MARKET SIZE, BY BLUNT TIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CANNULA MARKET SIZE, BY TROCAR TIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CANNULA MARKET SIZE, BY TROCAR TIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CANNULA MARKET SIZE, BY TROCAR TIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CANNULA MARKET SIZE, BY STANDARD CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CANNULA MARKET SIZE, BY STANDARD CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CANNULA MARKET SIZE, BY STANDARD CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CANNULA MARKET SIZE, BY CURVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CANNULA MARKET SIZE, BY CURVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CANNULA MARKET SIZE, BY CURVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CANNULA MARKET SIZE, BY STRAIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CANNULA MARKET SIZE, BY STRAIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CANNULA MARKET SIZE, BY STRAIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CANNULA MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CANNULA MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CANNULA MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CANNULA MARKET SIZE, BY SILICONE COATED STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CANNULA MARKET SIZE, BY SILICONE COATED STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CANNULA MARKET SIZE, BY SILICONE COATED STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CANNULA MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CANNULA MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CANNULA MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CANNULA MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CANNULA MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CANNULA MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CANNULA MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CANNULA MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CANNULA MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CANNULA MARKET SIZE, BY HIP ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CANNULA MARKET SIZE, BY HIP ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CANNULA MARKET SIZE, BY HIP ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CANNULA MARKET SIZE, BY KNEE ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CANNULA MARKET SIZE, BY KNEE ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CANNULA MARKET SIZE, BY KNEE ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CANNULA MARKET SIZE, BY SHOULDER ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CANNULA MARKET SIZE, BY SHOULDER ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CANNULA MARKET SIZE, BY SHOULDER ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CANNULA MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CANNULA MARKET SIZE, BY LIPOSUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CANNULA MARKET SIZE, BY LIPOSUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CANNULA MARKET SIZE, BY LASER-ASSISTED LIPOSUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CANNULA MARKET SIZE, BY LASER-ASSISTED LIPOSUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CANNULA MARKET SIZE, BY LASER-ASSISTED LIPOSUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CANNULA MARKET SIZE, BY TUMESCENT LIPOSUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CANNULA MARKET SIZE, BY TUMESCENT LIPOSUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CANNULA MARKET SIZE, BY TUMESCENT LIPOSUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CANNULA MARKET SIZE, BY ULTRASOUND-ASSISTED LIPOSUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CANNULA MARKET SIZE, BY ULTRASOUND-ASSISTED LIPOSUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CANNULA MARKET SIZE, BY ULTRASOUND-ASSISTED LIPOSUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CANNULA MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CANNULA MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CANNULA MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CANNULA MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CANNULA MARKET SIZE, BY CATARACT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CANNULA MARKET SIZE, BY CATARACT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CANNULA MARKET SIZE, BY GLAUCOMA SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CANNULA MARKET SIZE, BY GLAUCOMA SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CANNULA MARKET SIZE, BY GLAUCOMA SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CANNULA MARKET SIZE, BY VITRECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CANNULA MARKET SIZE, BY VITRECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CANNULA MARKET SIZE, BY VITRECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CANNULA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CANNULA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CANNULA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CANNULA MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CANNULA MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CANNULA MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CANNULA MARKET SIZE, BY HOMECARE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CANNULA MARKET SIZE, BY HOMECARE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CANNULA MARKET SIZE, BY HOMECARE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CANNULA MARKET SIZE, BY HOMECARE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CANNULA MARKET SIZE, BY HOMECARE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CANNULA MARKET SIZE, BY HOMECARE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CANNULA MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CANNULA MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CANNULA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CANNULA MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CANNULA MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CANNULA MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CANNULA MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CANNULA MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CANNULA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CANNULA MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CANNULA MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CANNULA MARKET SIZE, BY PLASTIC SURGERY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CANNULA MARKET SIZE, BY PLASTIC SURGERY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CANNULA MARKET SIZE, BY PLASTIC SURGERY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CANNULA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS CANNULA MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL CANNULA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 254. GCC CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. GCC CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. GCC CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 257. GCC CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 258. GCC CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 259. GCC CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 260. GCC CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. GCC CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. GCC CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 263. GCC CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 264. GCC CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 265. GCC CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. GCC CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 267. GCC CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 296. G7 CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. G7 CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. G7 CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 299. G7 CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 300. G7 CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 301. G7 CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 302. G7 CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. G7 CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 304. G7 CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 305. G7 CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 306. G7 CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 307. G7 CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. G7 CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 309. G7 CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 310. NATO CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 311. NATO CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. NATO CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 313. NATO CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 314. NATO CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 315. NATO CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 316. NATO CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 317. NATO CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 318. NATO CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 319. NATO CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 320. NATO CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 321. NATO CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. NATO CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 323. NATO CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 324. GLOBAL CANNULA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES CANNULA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED STATES CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED STATES CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 339. CHINA CANNULA MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 340. CHINA CANNULA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. CHINA CANNULA MARKET SIZE, BY DISPOSABLE CANNULA, 2018-2032 (USD MILLION)
  • TABLE 342. CHINA CANNULA MARKET SIZE, BY MICROCANNULA, 2018-2032 (USD MILLION)
  • TABLE 343. CHINA CANNULA MARKET SIZE, BY PENETRATING CANNULA, 2018-2032 (USD MILLION)
  • TABLE 344. CHINA CANNULA MARKET SIZE, BY STANDARD CANNULA, 2018-2032 (USD MILLION)
  • TABLE 345. CHINA CANNULA MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. CHINA CANNULA MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA CANNULA MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA CANNULA MARKET SIZE, BY LIPOSUCTION, 2018-2032 (USD MILLION)
  • TABLE 349. CHINA CANNULA MARKET SIZE, BY OPHTHALMIC, 2018-2032 (USD MILLION)
  • TABLE 350. CHINA CANNULA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 351. CHINA CANNULA MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 352. CHINA CANNULA MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)